MedTrace Logo

Berlin Registry of Right Heart Interventions

NCT04570163 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-03-19

No results posted yet for this study

Summary

The present study evaluates patients after interventional therapy of valvular diseases of the right heart. Follow-up examinations include medical history taking, laboratory measurements and an echo. The aim is to assess the different interventional therapies and their impact on patient's outcome.

Conditions

  • Tricuspid Regurgitation
  • Pulmonary Regurgitation

Interventions

DEVICE

Interventional therapy mainly of tricuspid regurgitation (TriClip, Cardioband)

Catheter-based therapy of valve diseases of the right heart with various devices (e. g. TriClip, Cardioband).

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-16
Primary Completion
2035-12-31
Completion
2035-12-31
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04570163 on ClinicalTrials.gov